Patent Number: 6,841,684

Title: Imidiazoles having reduced side effects

Abstract: Methods and compounds for the treatment of conditions including pain, particularly chronic pain, glaucoma or elevated intraocular pressure with reduced cardiovascular or sedative side effects. Also included are methods of making and using such compounds.

Inventors: Chow; Ken (Newport Coast, CA), Gil; Daniel W. (Corona Del Mar, CA), Burke; James A. (Santa Ana, CA), Harcourt; Dale A. (Irvine, CA), Garst; Michael E. (Newport Beach, CA), Wheeler; Larry A. (Irvine, CA), Munk; Stephen A. (Northville, MI), Gomez; Dario G. (Irvine, CA), Heidelbaugh; Todd M. (Fountain Valley, CA)

Assignee: Allergan, Inc.

International Classification: C07D 233/10 (20060101); C07D 233/06 (20060101); C07D 405/00 (20060101); C07D 403/06 (20060101); C07D 405/06 (20060101); C07D 233/84 (20060101); C07D 233/00 (20060101); C07D 233/54 (20060101); C07D 413/00 (20060101); C07D 263/00 (20060101); C07D 409/00 (20060101); C07D 409/06 (20060101); C07D 263/28 (20060101); C07D 413/12 (20060101); C07D 401/00 (20060101); C07D 403/00 (20060101); C07D 401/06 (20060101); C07D 495/00 (20060101); C07D 495/04 (20060101); C07D 233/64 ()

Expiration Date: 1/11/02017